J Korean Endocr Soc.  2008 Feb;23(1):51-55. 10.3803/jkes.2008.23.1.51.

A Case of Unilateral Exophthalmos Caused by a Dural Arteriovenous Malformation in Thyroid-Associated Ophthalmopathy

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Hallym University, Korea.

Abstract

Thyroid-associated ophthalmopathy is associated with thyroid dysfunction, particularly Graves' disease, and is manifested as eye signs, including proptosis. In cases of unilateral exophthalmos with thyroid-associated ophthalmopathy, other causes such as orbital neoplasm, carotid-cavernous fistula, cavernous sinus thrombosis, and dural arteriovenous malformation (AVM) should be excluded. Dural AVM, an abnormal dural arteriovenous connection, is a rare neurovascular entity that mimics thyroid-associated ophthalmopathy. When eye involvement is unilateral or asymmetric, dural AVM can be considered in the differential diagnosis of thyroid-associated ophthalmopathy. A twenty-six year-old woman presented with unilateral exophthalmos in Graves' disease. By orbital magnetic resonance imaging and cerebral angiography, thyroid-associated ophthalmopathy and dural AVM were diagnosed. The unilateral exophthalmos improved after coil embolization of the dural AVM. In summary, we report the first case of a dural AVM with Graves' disease and thyroid-associated ophthalmopathy.

Keyword

dural arteriovenous malformation; exophthalmos; thyroid-associated ophthalmopathy

MeSH Terms

Arteriovenous Malformations
Cavernous Sinus Thrombosis
Cerebral Angiography
Diagnosis, Differential
Exophthalmos
Eye
Female
Fistula
Graves Disease
Graves Ophthalmopathy
Humans
Magnetic Resonance Imaging
Orbit
Orbital Neoplasms
Thyroid Gland

Figure

  • Fig. 1 Orbital MRI. Right exophthalmos, both extraocular muscle thickening and right retro-orbital vessel engorgement (arrow) are seen.

  • Fig. 2 Cerebral angiography reveals dural arteriovenous malformation (AVM) without cortical venous reflex, so called type I AVM (arrows).

  • Fig. 3 After selection of dural AVM, coil embolization was performed in abnormal vessel.


Reference

1. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000. 21:168–199.
2. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003. 24:802–835.
3. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 1993. 14:747–793.
4. Drescher EP, Benedict WL. Asymmetric exophthalmos. Arch Ophthal. 1950. 44:109–128.
5. DeSanto LW. The total rehabilitation of Graves' ophthalmopathy. Laryngoscope. 1980. 90:1652–1678.
6. Loré F, Polito E, Cerase A, Bracco S, Loffredo A, Pichierri P, Talidis F. Carotid cavernous fistula in a patient with Graves' ophthalmopathy. J Clin Endocrinol Metab. 2003. 88:3487–3490.
7. Werner SC. Classification of the eye changes Graves' disease. J Clin Endocrinol Metab. 1969. 29:982–984.
8. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989. 73:639–644.
9. The European Group on Graves' Orbitopathy. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol. 2006. 155:387–389.
10. Enzmann DR, Donaldson SS, Kriss JP. Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr. 1979. 3:815–819.
11. Wiersinga WM, Smit T, van der Gaag R, Mourits M, Koornneef L. Clinical presentation of Graves' ophthalmopathy. Ophthalmic Res. 1989. 21:73–82.
12. Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F 4th. Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. AJNR Am J Neuroradiol. 1986. 7:651–656.
13. Fledelius HC, Glydensted C. Ultrasonography and computed tomography in orbital diagnosis: with special reference to dysthyroid ophthalmopathy. Acta Ophthalmol(Copenh). 1978. 56:751–762.
14. Dallow RL. Evaluation of unilateral exophthalmos with ultrasonography: analysis of 258 consecutive cases. Laryngoscope. 1975. 85:1905–1919.
15. Kahaly GJ. Imaging in thyroid-associated orbitopathy. Eur J Endocrinol. 2001. 145:107–118.
16. Kerber CW, Newton TH. The macro and microvasculature of the dura mater. Neuroradiology. 1973. 6:175–179.
17. Awad IA, Little JR, Akarawi WP, Ahl J. Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg. 1990. 72:839–850.
18. Lawton MT, Jacobowitz R, Spetzler RF. Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg. 1997. 87:267–274.
19. Kiyosue H, Hori Y, Okahara M, Tanoue S, Sagara Y, Matsumoto S, Nagatomi H, Mori H. Treatment of intracranial dural arteriovenous fistulas: current strategies based on location and hemodynamics, and alternative techniques of transcatheter embolization. Radiographics. 2004. 24:1637–1653.
20. Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg. 1995. 82:166–179.
21. Houser OW, Baker HL Jr, Rhoton AL Jr, Okazaki H. Intracranial dural arteriovenous malformations. Radiology. 1972. 105:55–64.
22. Djindjian R, Merland J. Meningeal arteriovenous fistula. Superselective arteriography of the external carotid artery. 1978. New York: Springer-Verlag;405–406.
Full Text Links
  • JKES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr